scholarly journals Erectile Dysfunction and Cardiovascular Disease

2007 ◽  
pp. 2791-2801
Author(s):  
Sanjay Kaul ◽  
James S. Forrester
Keyword(s):  
Cardiovascular Disease ◽  
Erectile Dysfunction

Erectile Dysfunction in the Patients with Cardiovascular Disease

2006 ◽  
Vol 47 (3) ◽  
pp. 279 ◽  
Author(s):  
Hyun Woo Kim ◽  
Wang Jin Park ◽  
Su Yeon Cho
Keyword(s):  
Cardiovascular Disease ◽  
Erectile Dysfunction

scholarly journals Disfungsi ereksi pada penyakit kardiovaskular

2016 ◽  
Vol 8 (1) ◽  
Author(s):  
Nancy Sasube ◽  
Starry H. Rampengan
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Disease ◽  
Erectile Dysfunction ◽  
Sexual Function ◽  
Risk Mitigation ◽  
Time Frame ◽  
Lifestyle Changes ◽  
Cvd Risk ◽  
Adherence To Medication

Abstract: Erectile dysfunction (ED) is common among cardiovascular disease (CVD) patients. It is an important component of the quality of life. Moreover, it also confers an independent risk for future CV events. There is usual a 3-year time frame between the onset of ED symptoms and a CV event which offers an opportunity for risk mitigation. Thus, sexual function should be incorporated into CVD risk assessment for all males. Algorithms for the management of patient with ED have been proposed according to the risk for sexual activity and future (comprising of both lifestyle changes and pharmacological treatment) improve overall vascular health, including sexual function. Proper sexual counselling improves the quality of life and increase adherence to medication. Testosterone assessment may be useful for both diagnosis of ED, risk stratification, and further management. There are issues to be addressed, such as whether PDE5 inhibitors reduce CV risk. Management of ED requires a collaborative approach and the role of the cardiologist is pivotal.Keywords: cardiovascular disease, erectile dysfunction, sexual functionAbstrak: Disfungsi ereksi (DE) umumnya ditemukan pada pasien dengan penyakit kardiovaskular. DE merupakan komponen penting terhadap penurunan kualitas hidup pada laki-laki dan merupakan indikator terhadap risiko kejadian penyakit kardiovaskular di masa depan. Terdapat jangka waktu sekitar 3 tahun antara munculnya DE dan kejadian penyakit kardiovaskular, sehingga masih ada kesempatan untuk mencegah risiko yang akan terjadi. Dengan demikian fungsi seksual harus dimasukkan dalam penilaian risiko penyakit kardiovaskular pada semua laki-laki. Algoritma untuk penanganan pasien DE telah dirumuskan sesuai dengan risiko aktivitas seksual dan kejadian penyakit kardiovaskular di masa depan. Beberapa pendekatan untuk mengurangi resiko penyakit kardiovaskular terdiri dari perubahan gaya hidup dan pengobatan farmakologi dapat meningkatkan kesehatan termasuk fungsi seksual. Konseling seksual yang tepat dapat meningkatkan kualitas hidup dan meningkatkan kepatuhan terhadap pengobatan. Penggunaan testosteron dan inhibitor PDE5 dapat bermanfaat dalam pengobatan DE. Penanganan DE memerlukan kerjasama dari berbagai bidang spesialistik termasuk peran dari kardiologis.Kata kunci: disfungsi ereksi, fungsi seksual, penyakit kardiovaskular

scholarly journals Erectile Dysfunction and Risk of Cardiovascular Disease

2011 ◽  
Vol 58 (13) ◽  
pp. 1378-1385 ◽  
Author(s):  
Jia-Yi Dong ◽  
Yong-Hong Zhang ◽  
Li-Qiang Qin
Keyword(s):  
Cardiovascular Disease ◽  
Erectile Dysfunction

Erectile Dysfunction: Evaluation, Including Diagnostic Studies (Doppler Ultrasound, Cavernosography/Cavenosometry)

2017 ◽  
Author(s):  
Sevann Helo ◽  
Nicholas Tadros ◽  
Kevin T McVary
Keyword(s):  
Cardiovascular Disease ◽  
Erectile Dysfunction ◽  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Diagnostic Testing ◽  
Male Hypogonadism ◽  
Male Impotence ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Erectile dysfunction (ED) is a common condition in the aging population that can be broadly classified as organic, psychogenic, or mixed. A thorough evaluation of a patient with ED begins with acknowledging that it is intimately related to a host of medical, neurologic, and psychological conditions. Providers should be confident in their ability to obtain a relevant history, perform a targeted physical exam, and, when indicated, select appropriate diagnostic testing. Patients should also be evaluated for associated urologic conditions, including male hypogonadism and lower urinary tract symptoms, the treatment of which may improve ED symptoms. It is also important that clinicians be aware that ED may be a “sentinel event” for undiagnosed cardiovascular disease as the implications of intervention can potentially be lifesaving. This review contains 7 figures, 10 tables and 138 references Key words: cardiovascular disease, Doppler ultrasonography, erectile dysfunction, hypogonadism, lower urinary tract symptoms, male impotence, metabolic syndrome, penile tumescence, Peyronie disease, premature ejaculation, sexual desire, testosterone

Drugs

ESC CardioMed ◽  
2018 ◽  
pp. 1030-1035
Author(s):  
Mike Kirby ◽  
Jonny Coxon
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Disease ◽  
Erectile Dysfunction ◽  
Negative Effects ◽  
Phosphodiesterase Type 5 Inhibitors ◽  
Cardiac Condition ◽  
Male Patients ◽  
Phosphodiesterase Type ◽  
The Impact

It should not be presumed that male patients with cardiovascular disease are less sexually active than others, but they are more likely to have erectile dysfunction. It is therefore crucial to consider the impact on sexual function of medications commonly used to treat cardiovascular disease, because negative effects on erectile dysfunction can lead to problems with compliance and quality of life. Cardiovascular implications of phosphodiesterase type 5 inhibitors used to treat erectile dysfunction should be borne in mind. Effective treatment of the cardiac condition should always take priority.

Sign in / Sign up

Export Citation Format

Share Document